Emily M. Leproust - 26 Jun 2024 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 Jun 2024, 16:18:11 UTC
Prior SEC filing
24 Jun 2024
Next SEC filing
05 Jul 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Devin Schaffer, Attorney-in-Fact

Key filing fact

Emily M. Leproust filed Form 4 for GeneDx Holdings Corp. (WGS) on 27 Jun 2024.

Key facts

  • This page summarizes Emily M. Leproust's Form 4 filing for GeneDx Holdings Corp. (WGS).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 27 Jun 2024, 16:18.

Change

  • Previous filing in this sequence was filed on 24 Jun 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

WGS transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+12,924
Change %
Price
$0.000000
Shares after
12,924
Date
26 Jun 2024
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
12,924
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.

Footnote F2

The RSUs shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .